Healthcare -
Biotechnology - NASDAQ - US
$ 4.125
-2.6 %
$ 1.35 B
Market Cap
-3.22
P/E
IOVA - LONG-TERM DEBT
Long-term Debt IOVA - Iovance Biotherapeutics, Inc.
68.1 M
LAST VALUE
1.20%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR